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Benign leiomyomas of the uterus are uncommonly found in association with benign smooth muscle tumors
beyond the confines of the uterus. Benign metastasizing leiomyoma (BML) is a rare disease in which the lung is
described to be the most afflicted extrauterine organ. We present a brief review of the literature, along with case
reports for four patients who were followed up after resection of a pulmonary lesion or after pathological
confirmation by biopsy. The clinical course of BML varies from chronic asymptomatic appearance to rapid
progression, leading to respiratory failure and death. Our BML patients did not complain of pulmonary symptoms,
such as cough, dyspnea, or chest tightness. Pathology revealed benign leiomyomas with no atypia and mitotic
activity <5 per 10 high-power field. Immunohistochemical staining was positive for actin and desmin. A standard
treatment for BML has not yet been established. Because of the hormone-sensitive characteristics of BML,
treatments are based on hormonal manipulation along with either surgical or medical oophorectomy. Benign
metastasizing leiomyoma can be observed in postmenopausal women. We observed four patients who did not
receive adjuvant hormonal therapy because they were postmenopausal or perimenopausal. All patients are still
healthy and show no evidence of recurrence or progression of the disease.
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Uterine leiomyomas, the most common gynecological
neoplasms in women of reproductive age, have a preva-
lence of about 50% in women older than 30 years and
result from clonal proliferation of uterine smooth muscle
tissue [1,2]. Very rarely, benign uterine leiomyomas
display bizarre growth patterns, including intravascular
leiomyomatosis, disseminated peritoneal leiomyomatosis,
and benign metastasizing leiomyoma (BML) [3]. Benign
metastasizing leiomyoma is an ill-defined clinicopatholog-
ical condition that features histologically benign ‘meta-
static’ smooth muscle tumor [4]. BML is a very rare
disease that has been reported in association with uter-
ine leiomyoma, and about 100 cases have been reported
in the literature [5]. The term ‘benign metastasizing
leiomyoma’, which was coined initially by Steiner in
1939, is used to describe the presence of benign smooth
muscle tumors in an organ distant from the uterus [6].
It affects women of reproductive age who have under-* Correspondence: hursy@catholic.ac.kr
Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, The
Catholic University of Korea, #505 Banpo-Dong, Seocho-Gu, Seoul, South
Korea
© 2013 Ki et al.; licensee BioMed Central Ltd. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the orbenign-appearing uterine leiomyomas [7,8]. The lung is
the most common site of involvement. In addition to
pulmonary lesions, lesions of the mediastinum, the ner-
vous system, skin, and bone have been described, with
similar growth characteristics [3,9,10]. Although most
tumors are asymptomatic and are found incidentally on
routine chest X-rays, a few tumors induce cough, dyspnea,
and decreased pulmonary function [8,11,12].Case presentation
Case 1
A 53-year-old primiparous woman was referred to the
cardiothoracic and vascular surgery outpatient clinic of
our hospital for further evaluation of chronic cough and
hemoptysis. Chest computed tomography (CT) showed
a 10 cm solitary lung nodule with haziness in the left
upper lobe. The patient’s breathing sound decreased.
She did not have any specific past history. She had en-
tered menopause at the age of 50. She had been diag-
nosed with a small uterine myoma 3 years prior to this
presentation but had not received any treatment. She
underwent excisional biopsy of the mass. Pathologic
diagnosis was benign metastatic leiomyoma. Masson tri-
chrome staining revealed that the tumor cells were ofhis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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chemical staining was positive for actin. She did not re-
ceive further treatment and has remained healthy for
16 years.
Case 2
A 50-year-old woman (gravid 3, para 3) presented at our
clinic with a chief complaint of menorrhagia. Her men-
strual periods had been regular prior to this presenta-
tion. Transvaginal ultrasonography showed a 10 × 10 cm




Figure 1 Histology of the BML. (a) A well-circumscribed leiomyoma mas
positive for Masson’s trichrome stain. It reveals that the tumor is of smooth
spindle-shaped cells arranged in intersecting fascicles (H & E, ×400). Immun
(×400), (e) desmin (×400), (f) estrogen receptor (× 400), and (g) progestero
and a benign nature (×200).X-ray showed small multiple nodules of variable size in
both lower lung fields. She had not previously had pul-
monary disease, such as pulmonary tuberculosis or pneu-
monia. She did not complain of any chest symptoms, such
as cough, dyspnea, or chest pain. Chest CT showed mul-
tiple small well-defined scattered pulmonary nodules in
both lungs. The largest nodule measured 2.7 × 4.4 cm
(Figure 2). The patient underwent a total laparoscopic
hysterectomy along with a video-assisted thoracoscopic
lung biopsy. Analysis of the uterine and lung lesions re-
vealed leiomyoma and metastatic leiomyoma, respectively.s in the normal lung parenchyma (H & E, ×12.5). (b) The mass is
muscle nature (Masson’s trichrome, ×12.5). (c) Benign-appearing
ohistochemical staining was positive for: (d) smooth muscle actin
ne (×400). (h) Ki-67 is less than 1%, signifying a low proliferate status
Figure 3 Chest radiograph. There is a 2.6-cm well-defined oval
mass in the left lower lung (white arrow) and a small ovoid nodule
in the right upper lobe field (arrowhead).
Figure 2 Chest computed tomography (CT) shows multiple pulmonary nodules. (a) Largest nodule measures 2.7 × 4.4 cm (thick white arrow).
(b) Small variable nodules are seen in both lungs (narrow white arrow).
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(Figure 1c,d), desmin, estrogen receptors, and proges-
terone receptors. We decided to monitor the remaining
residual lung lesion: if the size of the remaining lung le-
sion increases, then bilateral salpingo-oophorectomy
with gonadotrophin-releasing hormone agonist (GnRH)
therapy will be instituted. She has remained healthy for
3 months without evidence of disease progression.
Case 3
A 49-year-old primiparous perimenopausal woman was
referred to the cardiothoracic and vascular surgery out-
patient clinic of our hospital for further evaluation of in-
cidental lung masses. A chest X-ray showed a 2.5-cm
round nodule in the left lower lobe and a smaller well-
defined ovoid nodule in the right upper lobe (Figure 3).
The patient underwent myomectomy at the age of 42
years and total abdominal hysterectomy at the age of 43
years, due to recurrence. There was no significant family
history. The patient had no pulmonary symptoms. Chest
CT showed a 2.5-cm well-defined round nodule with
poor contrast enhancement in the left lower lobe and a
smaller well-defined ovoid nodule in the right upper lobe.
The patient underwent a video-assisted thoracoscopic
wedge resection of the left lower lobe and right upper
lobe.The mass shows a irregular pale brown tissue frag-
ment (Figure 4). Pathologic diagnosis was leiomyoma of
the lung. Immunohistochemical staining was positive for
desmin and actin (Figure 1e). Transvaginal sonography
showed no abnormal findings other than atrophic ovaries.
Because the patient was perimenopausal, we decided to
monitor her for the progression of the disease. She was
healthy without evidence of progression of disease 2
months following the surgery.
Case 4
A 48-year-old nulliparous perimenopausal woman visited
our clinic with a huge abdominal lump. She was diagnosed
with systemic lupus erythematosus and underwent uterine
myomectomy. She had undergone uterine myomectomy
11 years back. Uterine myoma recurred 1 year ago.Computed tomography showed a 10.5 × 10.5 cm
heterogenous, low-density lesion on the right side of the
uterus and multiple low-attenuated foci on the left side.
There were multiple small nodules in both lungs. The pa-
tient underwent total abdominal hysterectomy along with
left adnexectomy. She underwent lung needle biopsy of
the multiple nodules. Pathologic diagnosis was leiomyoma
of the uterus and lung. Immunohistochemical staining
was positive for actin ,desmin,estrogen receptor and pro-
gesterone receptor (Figure 1f,g) Ki-67 is less than 1%
(Figure 4h). We decided to observe the residual lung le-
sion. The patient was healthy without recurrence, for 2
years following the surgery.
Discussion
Benign metastasizing leiomyoma is a uterine leiomyoma
with pulmonary metastasis occurring in young adult-
hood, especially during the premenopausal period.
Figure 4 Photograph of a lung nodule. An irregular pale brown tissue fragment, measuring 4.0 × 0.5 cm.
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three categories in 1982: (1) BML in women, (2) meta-
static leiomyoma in men and children, and (3) multiple
pulmonary fibroleiomyomatous hamartoma, occurring in
any subjects. The author reported that these are all patho-
logically identical but, on the basis of clinical manifesta-
tions, BML and multiple pulmonary fibroleiomyomatous
hamartomas are separate disease entities. In this study,
the BMLs of the lung in women were hormone-sensitive,
so they have good prognoses.
The pathogenesis of BML of the lung has not yet been
completely identified. Various pathogenetic mechanisms
have been proposed: hormone-sensitive in situ prolifera-
tion of smooth muscle bundles [14], benign smooth muscle
cells transported from a uterine leiomyoma and colonized
in the lung, and low-grade uterine leiomyosarcoma metas-
tasized to the lung [15]. The possibility of surgically in-
duced mechanical displacement from the preexisting
benign uterine tumor has been suggested because BML
usually develops several years after the resection of uterine
leiomyomas but rarely after Cesarean section [14,16,17].
Recently, Nucci et al. [18] described consistent chromo-
somal aberrations (19q and 22q terminal deletion) in BML
cases and suggested that BML can be affected genetically.
Of our four patients, two who had been diagnosed with
BML were also diagnosed with myoma at our clinic. Kayser
et al. [19] reported that the mean interval between hyster-
ectomy and the development of lung lesions was 14.9
years. In our two cases, the mean interval between hyster-
ectomy and the development of lung lesions was 9 years.
Pathological features are of a benign nature. Cytologic
atypia, coagulative tumor cell necrosis, increased mitoses
(> 5 per 10 high-power field) with a low Ki-67 index,
and the absence of high cellularity, support the low pro-
liferative state and the benign nature of these tumors.
Histologic examination reveals interlacing fascicles of
smooth muscle cells without anaplasia or vascular inva-
sion, with entrapped respiratory epithelium [5]. Various
immunohistochemical markers, such as desmin, muscle-specific actin, and vimentin, confirm mesenchymal
derivation with smooth muscle differentiation of these
tumors [20]. The presence of estrogen and progesterone
receptors suggests the derivation of BML from the female
genital tract, which supports the rationale for treatment
with hormonal agents [20,21].
Radiologically, BML appears as a well-circumscribed
nodule a few millimeters to a few centimeters in size and
can be found as a solitary lesion or as multiple lesions
scattered within the normal interstitium [22]. It does not
enhance with intravenous contrast medium. Endobronchial
and pleural sparing is characteristic of BML [5,22]. Military
patterns, cavitary nodules, interstitial lung disease, and
multiloculated fluid-containing cystic lesions have rarely
been reported in BML [12,23-25]. Horstmann et al. [26]
reported, in a radiologic evaluation, that multiple nodules
(87%, bilateral; 70% and unilateral, 17%) with a solitary
nodule occurred only in 13% of all patients. Such nodules
may remain unchanged, increase or decrease in size, or,
rarely, became cystic [4,12]. In our cases, one patient
showed a single solitary nodule, one patient showed two
solitary nodules, one in each lung, and two patients
showed multiple nodules in both lungs.
Benign metastasizing leiomyoma is similar to lymphangi-
oleiomyomatosis (LAM) in the following aspects: prolif-
eration of the smooth muscle cells, location in the lung,
hormonal dependence, and HMB-45 immunoreactivity
[27]. Lymphangioleiomyomatosis showed proliferation of
atypical smooth muscle cells along with lymphatics, blood
vessels, and small airways. In contrast, it has been shown
that lymphatics, blood vessels, and small airways are spared
in BML [28]. Immunohistochemical staining is useful for
differential diagnosis between BML and LAM. Human mel-
anoma black (HMB-45) is used to confirm the melanocytic
origin of cells. Patients with LAM are positive for HMB-45,
while those with BML are negative for HMB-45 [6].
A standard treatment of BML has not yet been
established. Because of the hormone-sensitive character-
istics of BML, its treatments are based on hormonal
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tomy. Moreover, regression of metastatic lesions has
been demonstrated in situations where estrogen levels
fall significantly, especially after termination of preg-
nancy and menopause [2,10]. For this reason, some au-
thors observed and closely followed up patients after
pathologic confirmation in perimenopause or postmeno-
pausal women. The duration of observation differs be-
tween reports (6 months to 14 years) (Table 1) [9,29,30].
Hoetzenecker et al. [30] proposed a ‘wait-and-see strat-
egy’ and observed one patient with multiple bi-lobar
BML for 14 years. Our patients were all in the peri-
menopausal or postmenopausal state, so we decided to
observe them. The follow-up duration ranged from 2
months to 16 years.
Reversible medical castration with GnRH agonists,
which suppress endogenous gonadotropin secretions re-
quired for gonadal steroid production, has been de-
scribed with good therapeutic outcomes in several
reports [3,4,31,32]. Egberts et al. [4] reported that treat-
ment with GnRH agonists suppressed lung nodules
without any increase in size for a period of 36 months.
Mogi et al. [31] also indicated that the use of GnRH ag-
onists can lead to shrinkage of lung nodules.
Progesterone therapy has been shown to be effective in
both prophylaxis against recurrence and regression of
BML [11,33,34,36]. The basis for the use of progestin lies
in its ability to suppress the hypothalamic-pituitary-







Rivera et al. [3] 2 11 years 6 cm
3 years 22 × 16 ×
Egberts et al. [4]. 1 10 years -
Mogi et al. [31]. 1 7 years 14 m
Bodner-Alder et al. [32]. 1 1 year 6 × 7 cm,
Nasu et al. [10]. 1 10 years -
Beck et al. [33]. 1 5 years 10 × 10 cm
Wentling et al. [34]. 1 6 years 5 cm
Goyle et al. [11]. 1 5 years -
Moon et al. [9]. 1 - 6 × 5 cm
Awonuga et al. [35]. 2 3 years 21 cm
6 years Six, ~30 cm
Ki et al. (this case report) 4 None Small
None 10 × 10 cm
7 years 8 × 8 cm,
11 years 10.5 × 8 cMoreover, progesterone increases the enzymatic inactiva-
tion rate of estradiol and reduces aromatase activity by up
to 30% [3]. Wentling et al. [34] documented a complete
disappearance of lung lesions after treatment with oral
progestin, (megestrol acetate) at a dose of 0.04 g three
times daily for 3 months, even in the presence of intact
ovarian function. Beck et al. [33] reported regression of
lung lesions with oral progestin after total hysterectomy
along with bilateral salpingo-oophorectomy one year after
operation.
Estrogen receptor antagonists, such as tamoxifen, are
used to treat BML. Säynäjäkangas et al. [8] reported a
47-year old woman who had been treated with tamoxi-
fen and had a stable disease for about 1 year. However,
Abramson et al. [37] reported a BML patient who had
been unsuccessfully treated with tamoxifen.
Aromatase inhibitors have been used to treat BML.
Aromatase-P450, an enzyme involved in the last step of
estrogen biosynthesis, is widely distributed throughout
the body. Anastrozole and other selective nonsteroidal
inhibitors of this enzyme reduce estradiol concentrations
by acting on both the gonads and peripheral and tumor
tissues [3]. Nasu et al. [10] reported a 46-year-old
woman who was treated with oral anastrozole after total
hysterectomy with bilateral salpingo-oophorectomy and
showed a stable disease for 15 months after operation.
The clinical course of BML varies from a chronic
asymptomatic course to a rapid progression leading to re-





10 cm, intramural GnRH agonist tamoxifen,
aromatase inhibitor
2 years
GnRH agonist 3 years
GnRH agonist -
subserosal GnRH agonist 3 months
Aromatase inhibitor 15 months





(multiple) Tamoxifen 2 years
Observation 16 years
Observation 3 months
5 × 7 cm Observation 2 months
m, subserosal Observation 2 years
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13% of the patients died within two years, and 46% sur-
vived longer than four years. They also stated that the lon-
gest survival period was 36 years (one patient with
extensive lung involvement). One of the important prog-
nostic factors is thought to depend on the estrogen or
progesterone status of the patient because BML is associ-
ated with hormonal receptors [39,40]. Horstmann et al.
[26] mentioned that the disease process is indolent in
postmenopausal patients, while progressive respiratory
compromise and even death occur in the premenopausal
patients. In this context, Nasu et al. [10] documented that
an individual treatment strategy should be considered for
each patient depending on the size and location of the
tumor and the hormone receptor status.
Conclusions
In this report, we reviewed four cases of perimenopausal
or postmenopausal women with BML who were followed
up after surgery. BML is a rare disease, and its standard
treatment remains to be established. Because the clinical
course of BML varies among cases, an individual approach
should be considered.
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